CA1338319C - Derives de la cyclosporine avec 8-aminoacide modifie - Google Patents
Derives de la cyclosporine avec 8-aminoacide modifieInfo
- Publication number
- CA1338319C CA1338319C CA 585752 CA585752A CA1338319C CA 1338319 C CA1338319 C CA 1338319C CA 585752 CA585752 CA 585752 CA 585752 A CA585752 A CA 585752A CA 1338319 C CA1338319 C CA 1338319C
- Authority
- CA
- Canada
- Prior art keywords
- alanine
- fluoro
- deutero
- cyclosporin
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6467487A | 1987-06-22 | 1987-06-22 | |
US064,674 | 1987-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1338319C true CA1338319C (fr) | 1996-05-07 |
Family
ID=22057543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 585752 Expired - Fee Related CA1338319C (fr) | 1987-06-22 | 1988-12-13 | Derives de la cyclosporine avec 8-aminoacide modifie |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA1338319C (fr) |
GB (1) | GB2206119B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0373260B1 (fr) * | 1987-06-22 | 1994-03-09 | Merck & Co. Inc. | Dérivés de cyclosporine avec un acide aminé modifié en position 8 |
CH679119A5 (fr) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
GB2227244A (en) * | 1989-01-19 | 1990-07-25 | Merck & Co Inc | Immunosuppressive fluorinated cyclosporin analogs |
GB8916901D0 (en) | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5214130A (en) * | 1990-02-27 | 1993-05-25 | Merck & Co., Inc. | Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
US5122511A (en) * | 1990-02-27 | 1992-06-16 | Merck & Co., Inc. | Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
JP3631490B2 (ja) | 1992-05-13 | 2005-03-23 | ノバルティス ファーマ株式会社 | シクロスポリン含有眼科用組成物 |
PT589843E (pt) | 1992-09-25 | 2002-04-29 | Novartis Ag | Composicoes farmaceuticas contendo ciclosporinas |
EP0696323A1 (fr) * | 1993-04-23 | 1996-02-14 | Novartis AG | Alanine racemase et gapdh du tolypocladium niveum recombines |
DK0789580T3 (da) | 1994-11-03 | 2002-09-09 | Novartis Ag | Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling |
DE19544507B4 (de) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
EP0988046B1 (fr) | 1997-01-30 | 2004-09-15 | Novartis AG | Compositions pharmaceutiques exemptes d'huile, a base de cyclosporine a |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
PL210841B1 (pl) | 2001-10-19 | 2012-03-30 | Isotechnika Inc | Sposób wytwarzania mieszaniny izomerów (E) i (Z) ISATX247 |
US11311477B2 (en) | 2006-03-07 | 2022-04-26 | Sgn Nanopharma Inc. | Ophthalmic preparations |
US10137083B2 (en) | 2006-03-07 | 2018-11-27 | SGN Nanopharma Inc | Ophthalmic preparations |
US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
US7696166B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
US7576057B2 (en) | 2006-11-20 | 2009-08-18 | Scynexis, Inc. | Cyclic peptides |
NZ594755A (en) | 2009-01-30 | 2013-12-20 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c infection |
US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8367053B2 (en) | 2009-07-09 | 2013-02-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8349312B2 (en) | 2009-07-09 | 2013-01-08 | Enanta Pharmaceuticals, Inc. | Proline substituted cyclosporin analogues |
US8685917B2 (en) | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
WO2012145427A1 (fr) | 2011-04-18 | 2012-10-26 | The Trustees Of Columbia University In The City Of New York | Méthodes de traitement du cancer à l'aide de cyclosporine et de dérivés de cyclosporine |
WO2014085623A1 (fr) | 2012-11-28 | 2014-06-05 | Enanta Pharmaceuticals, Inc. | Nouveaux analogues de [n-me-4-hydroxyleucine]-9-cyclosporine |
AU2014311346A1 (en) | 2013-08-26 | 2016-03-17 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues for preventing or treating hepatitis C |
WO2016073480A1 (fr) | 2014-11-03 | 2016-05-12 | Enanta Pharmaceuticals, Inc. | Analogues de cyclosporine pour prévenir ou traiter une infection par l'hépatite c |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0194972B1 (fr) * | 1985-03-11 | 1992-07-29 | Sandoz Ag | Cyclosporines |
-
1988
- 1988-06-20 GB GB8814598A patent/GB2206119B/en not_active Expired - Fee Related
- 1988-12-13 CA CA 585752 patent/CA1338319C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2206119A (en) | 1988-12-29 |
GB8814598D0 (en) | 1988-07-27 |
GB2206119B (en) | 1990-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1338319C (fr) | Derives de la cyclosporine avec 8-aminoacide modifie | |
EP0373260B1 (fr) | Dérivés de cyclosporine avec un acide aminé modifié en position 8 | |
US4885276A (en) | Cyclosporin analogs with modified "C-9 amino acids" | |
US4914188A (en) | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin | |
US5227467A (en) | Immunosuppressive fluorinated cyclosporin analogs | |
US4798823A (en) | New cyclosporin analogs with modified "C-9 amino acids" | |
CA1247546A (fr) | Cyclosporines | |
US4764503A (en) | Novel cyclosporins | |
JP5756227B2 (ja) | ノノムラエ種からの環状ペプチド、その生産プロセス、およびそれを含むマイコバクテリア関連疾病の治療または予防のための薬学的組成物 | |
EP0056782A1 (fr) | Cyclosporines | |
EP0444897A1 (fr) | Nouvelles analogues immunosuppressives de la cyclosporine avec des acides aminées modifiées dans la position 8 | |
HUT70207A (en) | 21-norrapamycin, pharmaceutical compositions containing it and process for preparing them | |
GB2207678A (en) | Novel immunosuppressive fluorinated cyclosporin analogs | |
JPH03218396A (ja) | シクロスポリン誘導体 | |
WO2000009137A2 (fr) | Composes aminosteroliques et utilisations correspondantes | |
JPH08506118A (ja) | 7,42−ビス(o−デメチル)ラパマイシン | |
JP3107584B2 (ja) | 抗生物質ge2270因子b1、b2、c1、c2、d1、d2、eおよびt | |
US7199099B2 (en) | Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria | |
EP1142905B1 (fr) | Nouveau compose a base de depsipeptide | |
US5514649A (en) | Antibiotic GE 2270 factors C2a | |
US7375230B2 (en) | Fermentation and purification of migrastatin and analog | |
DE102004011988A1 (de) | Cyclosporinderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
JP2997480B2 (ja) | 抗生物質ge2270 | |
JPH0717677B2 (ja) | “8−アミノ酸”に改良のある新規シクロスポリン誘導体 | |
GB2227244A (en) | Immunosuppressive fluorinated cyclosporin analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |